China Nuokang Bio-Pharmaceutical News

Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to Market
Join us for a one-hour overview of the regulated clinical trials process used to bring a n
Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected Devices
After launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
Active Directory & the Cloud for Biotech & Pharma
Biotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ

Most Popular China Nuokang Bio-Pharmaceutical Story

Chinese firm files $69M IPO

November 24, 2009 — 3:24pm ET | By Liz Jones Hollis

China Nuokang Bio-Pharmaceutical, a company focused on hematological and cardiovascular drugs, has filed an IPO and will offer 4.5 million American Depositary Shares on the Nasdaq exchange at a price Read more...

Latest Headlines

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events

China Nuokang Bio-Pharmaceutical News

Most Popular China Nuokang Bio-Pharmaceutical Story

Chinese firm files $69M IPO

Latest Headlines

Paid Research Reports

THE FIERCEMARKETS NETWORK